This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Waters Technologies Corporation, a subsidiary of Waters Corporation, for the provision of two Waters HPLC (High-Performance Liquid Chromatography) systems. The contract, valued at $90,508.58, has an ultimate completion date of March 24, 2024. This award is not associated with a set-aside program. Waters Technologies Corporation is a leading manufacturer of sophisticated scientific instruments, software, and services, primarily focused on liquid chromatography, mass spectrometry, and thermal analysis technologies. The company has been awarded numerous prime federal contracts across various agencies to supply advanced analytical solutions, including liquid chromatography systems, mass spectrometers, and associated services. This contract aligns with the FDA's mission to ensure the safety and efficacy of the products it regulates, as HPLC systems are critical tools for pharmaceutical and medical device analysis and testing.
Generated 6/29/25, 1:30 AM